Programs & Services
Related Clinical Trials
The majority of Dr. Li’s current research is a) to define the specific CBD and sarcoidosis disease gene profiles and their function, b) to investigate the potential molecular and immunopathogenetic mechanisms suggested by these studies, and c) to identify possible surrogate biomarkers of CBD and sarcoidosis in the future. She strongly believe that by revealing the mechanisms of the granulomatous diseases, it will not only aid in the prevention or early diagnosis of CBD and sarcoidosis, but also provide insights into the potential therapeutic applications. It is also her goal to extend the results of the biomarker investigation by testing its application for use as a future clinical diagnostic.
||University of Ulm, Department of Internal Medicine, Ulm,
||Tongji Medical College, Huazhong University of Science & Technology, Wuhan, P.R.,
||Tongji Medical University, Wuhan, P.R.,
||China Medical University, Shenyang, P.R.,
||University of Colorado at Denver and Health Sciences Center, Department of Dermatology, Denver, Colorado,
Awards & Recognition
2007: Society of Investigative Dermatology, Eugene M. Farber Travel Award for Young Investigators
Division of Pulmonary and Critical Care Sciences, Department of Medicine, School of Medicine
Ask a Question through Patient Portal
to your My National Jewish Health
patient portal account to communicate with your care team, manage appointments, and more. Create an Account
National Jewish Health Main Campus
1400 Jackson St.
Denver, CO 80206
The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.
Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey